SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

46,043.89 -202.27
(-0.44%)

Dow Jones

6,628.50 -17.20
(-0.26%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

92.72 0.33
(0.36%)

EUR-INR

106.76 0.38
(0.35%)

GBP-INR

123.58 0.43
(0.35%)

JPY-INR

0.58 0.00
(0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524661

INE331C01025

1.0860857

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

0.86

30.9

EPS(TTM)

Face Value()

Div & Yield %

0.29

Back

Tanla Platforms consolidated net profit declines 3.96% in the September 2025 quarter

Oct 18,2025

Net profit of Tanla Platforms declined 3.96% to Rs 125.05 crore in the quarter ended September 2025 as against Rs 130.21 crore during the previous quarter ended September 2024. Sales rose 7.77% to Rs 1078.48 crore in the quarter ended September 2025 as against Rs 1000.72 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1078.48	1000.72	8
OPM %	16.46	17.53	-
PBDT	185.18	184.16	1
PBT	155.50	160.72	-3
NP	125.05	130.21	-4

74,532.96 325.72 ( 0.44%)

46,043.89 -202.27 (-0.44%)

6,628.50 -17.20 (-0.26%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

92.72 0.33 (0.36%)

106.76 0.38 (0.35%)

123.58 0.43 (0.35%)

0.58 0.00 (0.28%)